logo

TNGX

Tango Therapeutics·NASDAQ
--
--(--)
--
--(--)

TNGX fundamentals

Tango Therapeutics (TNGX) released its earnings on Nov 4, 2025: revenue was 53.81M (YoY +363.60%), beat estimates; EPS was -0.14 (YoY +48.15%), missed estimates.
Revenue / YoY
53.81M
+363.60%
EPS / YoY
-0.14
+48.15%
Report date
Nov 4, 2025
EPS
Revenue

Revenue & Expenses

TNGX has released its 2025 Q3 earnings report, with revenue of 53.81M, reflecting a YoY change of 363.61%, and net profit of 15.88M, showing a YoY change of 154.46%. The Sankey diagram below clearly presents TNGX's revenue sources and cost distribution.

Key Indicators

Tango Therapeutics (TNGX) key financial stats and ratios, covering profitability, financial health, and leverage.
Tango Therapeutics (TNGX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Tango Therapeutics (TNGX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Tango Therapeutics (TNGX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Tango Therapeutics (TNGX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Tango Therapeutics (TNGX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield